Immune-Image

Let’s dive into cell labelling! In this series, partner Danielle Vugts from Amsterdam UMC explains more about cell dynamics, labelling and strategies and how Immune-Image is benefitting this. We will kick-off with the question: what is the significance of cell labelling? #CellLabelling #Tracers #CancerTreatment #Immunotherapy #PET

Defending your PhD and publishing your second paper in PNAS in the same week is nothing short of remarkable! Great job, Yoline Lauwers?? Here's to celebrating this milestone and the exciting opportunities ahead! ??

This year, we’ve continued to push boundaries in immunotherapy imaging. Thank you to our researchers and collaborators for their dedication to advancing patient care. We wish you a festive season filled with joy and hope for a healthier future! Happy Holidays ???? #HealthyHolidays #HappyNewYear #Immunotherapy #CancerResearch

During the annual meeting, we took the opportunity to have a chat with project coordinator Bert Windhorst about the progress of ongoing clinical trials. In the video below, Bert shares exciting updates on how these trials are advancing. #ClinicalTrials #TotalBodyPET #ImmuneImaging #CancerTreatment #immunotherapy

We had the opportunity to speak with Jan-Willem Boiten, the leader of Work Package 2 (WP2) in the Immune-Image project. WP 2's main task is on data storage and analysis enablement. In the article, Jan-Willem shares exciting insights into the progress and future plans of his work package, highlighting the strides made in developing a robust data infrastructure that underpins the project’s clinical and imaging data needs.?Read more: https://lnkd.in/eEYU6DGd #DataStorage #DataInfrastructure #MolecularImaging #ImmuneImaging #immunotherapy

To align Immune-Image procedures with patient needs, a patient panel was set-up. The patient panel is divided into an oncology and an inflammatory disease taskforce. In the article we give an update about the patient panel. Read more: https://lnkd.in/eXgmeqUQ #PatientPanel #ImmunoImaging #ClinicalTrials #CancerTreatment #MolecularImaging

We interviewed Nick Devoogdt, Professor at Vrije Universiteit Brussel) and work package leader within Immune-Image, about the recent progress within his work package and the key areas he and his team are concentrating on until the end of the project. He also shares this thoughts about how Immune-Image can further build on the results of the project. Read more: https://lnkd.in/ekqGxnMe #nanobodies #PETTracer #immunotherapy #ImmunoImaging #NuclearImaging

Last week, our consortium gathered in Brussels for the 5th annual meeting. This year, we took a different approach by having several scientists present their own research data. The presentations sparked insightful questions, stimulating discussions, and generated fresh ideas. A big thank you to everyone who contributed to making this year’s meeting an inspiring and productive networking event! We look forward to continuing the excellent scientific work over the next 18 months and, hopefully, beyond. #Immunotherapy #consortium #ImmuneImaging #MolecularImaging #CancerTreatment Partners: Amsterdam UMC, Roche, Commissariat a l'Energie Atomique et aux Energies Alternatives, University of Tuebingen, The Janssen Pharmaceutical Companies of Johnson & Johnson, Bayer, Lygature, Novartis, Pfizer, Takeda, ttopstart , University of Cambridge, UMCG, Antaros Medical, Vall d'Hebron Institute of Oncology (VHIO), Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, University of Münster, Vrije Universiteit Brussel, VIB, ImaginAb and LAWRENCIUM LEGAL.

Exciting news: the very first paper with a tracer newly developed in Immune-Image has been published! The study explores the development of a nanobody-based immunotracer for non-invasive imaging of CD8+ T-cell dynamics. This breakthrough could significantly improve the effectiveness and safety of immunotherapies by allowing early patient stratification through precise SPECT and PET imaging. Read the paper here: https://lnkd.in/e7GSt9Zh #ImmunoImaging #NuclearImaging #Nanobodies #TCell #research

Researchers Melinda Badenhorst, Bert Windhorst and Wissam Beaino from our coordinator Amsterdam UMC published a paper on PD-1/PD-L1 imaging tracers. They created an overview of current PET tracers targeting the PD-1/PD-L1 axis, and researched ways to optimize antibody, peptide, and antibody fragment with respect to their molecular characteristics and binding properties. Read the paper here: https://lnkd.in/eqXhW2aq #PETtracer #MolecularImaging #ImmuneImaging #cancertreatment #immunotherapy